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Abstract
Background We investigated the analgesic efﬁcacy of
bilateral superﬁcial cervical plexus block in patients
undergoing thyroidectomy and to determine whether it
reduces the adverse effects of general anesthesia.
Methods We prospectively recruited 162 patients who
underwent elective thyroid operations from March 2006 to
October 2007. They were randomly assigned to receive a
bilateral superﬁcial cervical block (12 ml per side) with
isotonic saline (group A; n = 56), bupivacaine 0.5% (group
B; n = 52), or levobupivacaine 0.5% (group C; n = 54)
after induction of general anesthesia. The analgesic efﬁcacy
of the block was assessed with: intraoperative anesthetics
(desﬂurane), numbers of patients needing postoperative
analgesics, the time to the ﬁrst analgesics required, and pain
intensitybyvisualanalogscale(VAS).Postoperativenausea
and vomiting (PONV) for 24 h were also assessed by the
‘‘PONV grade.’’ We also compared hospital stay, operative
time, and discomfort in swallowing.
Results There were no signiﬁcant differences in patient
characteristics. Each average end-tidal desﬂurane concen-
tration was 5.8, 3.9, and 3.8% in groups A, B, and C,
respectively (p\0.001). Fewer patients in groups B and C
required analgesics (A: B: C = 33:8:7; p\0.001), and it
took longer before the ﬁrst analgesic dose was needed
postoperatively (group A: B: C = 82.1:360.8:410.1 min;
p\0.001). Postoperative pain VAS were lower in groups
B and C for the ﬁrst 24 h postoperatively (p\0.001).
Incidences of overall and severe PONV were lower, how-
ever, there were not sufﬁcient numbers of patients to detect
differences in PONV among the three groups. Hospital stay
was shorter in group B and group C (p = 0.011). There
was no signiﬁcant difference in operative time and post-
operative swallowing pain among the three groups.
Conclusions Bilateral superﬁcial cervical plexus block
reduces general anesthetics required during thyroidectomy.
It also signiﬁcantly lowers the severity of postoperative
pain during the ﬁrst 24 h and shortens the hospital stay.
Introduction
Thyroid operations can cause mild to moderate incisional
pain. In addition, discomfort in swallowing, burning
sensation in the throat, nausea, and vomiting can be caused
by the operation or by general anesthesia. These affect a
majority of the patients, especially within the ﬁrst day after
operation [1, 2]. Surgeons and anesthesiologists have
attempted to prevent or treat these problems with various
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drugs (NSAIDs), or with additional locoregional anesthesia
techniques. Locoregional anesthesia, such as local anes-
thetic wound inﬁltration (LWI), bilateral superﬁcial cervi-
cal plexus block (BSCPB), and bilateral combined
superﬁcial and deep cervical plexus block, can potentially
reduce postoperative pain in patients who undergo thyroid
operations [3–5].
Bilateral superﬁcial cervical plexus block (BSCPB) is a
popular regional anesthesia technique for its feasibility and
efﬁcacy. The aim of the present study was to investigate the
efﬁcacy of BSCPB by measuring postoperative pain visual
analog scores (VAS) and postoperative analgesic require-
ment and intraoperative inhalation anesthetics required. In
addition, we also wished to determine if BSCPB can reduce
swallowing pain, and postoperative nausea and vomiting
(PONV) in patients undergoing thyroidectomy.
Patients and methods
Patients
This study was approved by the Institutional Research
Board (IRB) of Tri-service General Hospital (TSGH). A
total of 179 patients underwent elective thyroid operations
at TSGH from March 2006 to October 2007. We excluded
17 patients because of redo operations (n = 10), recent
use of analgesics (n = 5, opioids or NSAIDs within
2 weeks), or inability to use the pain VAS scoring system
for pain assessment (n = 2). All procedures were per-
formed by the same team of anesthetists and surgeons
(2 anesthesiologists and 2 surgeons, 2 surgical nurses, and
1 research staff).
Materials and methods
Usingarandomnumbersequenceandsealedenvelopes,162
patients were assigned to receive a bilateral superﬁcial cer-
vical block (12 ml per side) with isotonic sodium chloride
(group A; n = 56), bupivacaine 0.5% (group B; n = 52), or
levobupivacaine 0.5% (group C; n = 54) after induction of
general anesthesia. Three auditory evoked potential (AEP)
electrodes (Danmeter A/S, Odense, Denmark) used to mea-
suredepthofanesthesiawereplacedatthemid-forehead(?),
left forehead (reference), and left mastoid (-) of all patients
before general anesthesia induction. Baseline arterial-line
autoregressive index (AAI) (A-Line Monitor; Danmeter
A/S) was recorded before anesthesia induction. General
anesthesia was induced with fentanyl 2 lg/kg, 2% lidocaine
(1.5 mg/kg), 2 mg cisatracurium, and 2–4 mg/kg propofol.
After of the patient lost consciousness, 1.5 mg/kg succinyl-
choline was administered and tracheal intubation was
performeduntiltheAAIdecreasedto20[6].Anesthesiawas
maintained with desﬂurane and oxygen. After general
anesthesia induction, BSCPB was performed by the surgeon
with a 22-gauge needle inserted into the mid-portion of the
posterior border of the sternocleidomastoid muscle 1–2 cm
deep, between the landmarks of mastoid process and C-6
transverse process. Next, 6 ml of anesthetic or saline was
injected horizontally and the other 6 ml was injected caudad
toward the sternal notch. After a 15-min high-ﬂow oxygen
wash-in (100% oxygen at a ﬂow rate of 2 l/min) to ﬁll the
functional residual capacity of the lungs, desﬂurane was
titrated in 100% oxygen at a ﬂow rate of 300 ml/min to
maintain an adequate anesthesia depth with a target AAI of
15–25 during the operation. The anesthesiologist who con-
trolled the desﬂurane titration during the procedure was
blinded to the study drug used. The BSCPB solutions were
prepared by a surgical nurse who did not participate in the
anesthesia care or evaluation of the patients. The AAI for all
patients was kept at a target value range of 20 ± 5; desﬂu-
rane concentration was reduced or increased by 2% in order
to keep the AAI within the target range. Supplemental fen-
tanyl (50 mcg) was prescribed in both groups if hemody-
namic control could not be achieved within 5 min by a
sequential2%increaseindesﬂuraneconcentration.TheAAI
was recorded at 1 h after skin incision and through the
operation to conﬁrm the level of AAI to be between 15 and
25. This is done to prevent awareness of patients by contin-
uously adjusting desﬂurane during maintenance of anesthe-
sia. If the AAI exceeded 25 or hypertension and tachycardia
developed, desﬂurane was adjustedby 2% increments; if the
AAI was less than 15 and was associated with hypotension,
weapplied2%decrementsofdesﬂurane.Theconcentrations
of end-tidal desﬂurane during operation were also recorded
in parallel with the AAI records. Average desﬂurane con-
centration is the exhaled desﬂurane concentration recorded
1 hfollowingBSCPBblockinallgroups,afterthedrugused
for BSCPB has stabilized.
After operation, patients were sent to the postanesthesia
care unit (PACU) for 1 h and then transferred to the ward.
We evaluated postoperative pain with VAS (0: no pain, to
10: the worst imaginable pain) once at PACU and then
every 4 h on the ward for 24 h. If the patient’s pain VAS
was higher than 4, rescue analgesics were administrated
with ketorolac 30 mg intravenously at 6-h intervals or
longer. Nausea and vomiting were evaluated by ‘‘PONV
score’’ as 1 = no nausea; 2 = mild nausea; 3 = severe
nausea; 4 = retching and/or vomiting. Severe PONV was
deﬁned as grades 3 and 4; mild or non-PONV was deﬁned
as grade 1–2 [2]. When severe PONV developed, rescue
antiemetics were administrated with metoclopramide
[7, 8]. Operative time, postoperative swallowing pain,
PONV, rescue analgesics, rescue antiemetics, and hospital
stay were recorded by a member of the research staff.
World J Surg (2010) 34:2338–2343 2339
123Statistical analyses
The continuous data were analyzed by the one-way anal-
ysis of variance (ANOVA) test, and categorical data were
tested by the chi-square test. Pain scores and analgesic
consumption are reported as median and range, and dif-
ferences between groups were analyzed with the nonpara-
metric Kruskal–Wallis test. The statistical software used
was S-Plus 2000 (CANdiensten, Amsterdam, The Nether-
lands). Differences were considered signiﬁcant at p\0.05.
Results
The demographics, types of operation, and intraoperative
additional fentanyl requirement in the three groups are
summarized in Table 1.
Desﬂurane requirements were lower in groups B and C
(Table 2). Each average end-tidal desﬂurane concentration
was 5.8 (± 0.58)%, 3.9 (± 0.56)%, and 3.8 (± 0.53)% in
groups A, B, and C, respectively (p\0.001; one-way
ANOVA test). Postoperative pain VAS (Fig. 1) showed
less pain in groups B and C than in group A at 2, 4, 8, 12,
16, 20, and 24 h after operation (p\0.001; nonparametric
Kruskal–Wallis test). There was no signiﬁcant difference
between groups B and C. Fifty-ﬁve patients developed
postoperative nausea and vomiting; including 19 severe
PONV (8, 5, and 6 in groups A, B, and C respectively) and
36 mild PONV (13, 14, and 9 in groups A, B, and C,
respectively) (Table 2).
Mean operative times were 152.9 min (range: 56.4–
345 min), 156.4 min (range: 55–395 min), and 164.1 min
(range: 49–337 min) (p = 0.492; one-way ANOVA test).
Mean hospital stays were 2.9 days (range: 1–5 days),
2.5 days (range: 1–6 days), and 2.4 days (range: 1–5 days)
(p = 0.011; one-way ANOVA test). Number of patients
requiringanalgesicswithin24 hpostoperativelyforthethree
groups were 33, 8, and 7 (p\0.001; chi-square test). Mean
times to ﬁrst postoperative analgesic requirement were 82.1,
360.8, and 410.1 min (p = 0.0004; one-way ANOVA
test) in groups A, B, and C, respectively. A total of 116
patients had pain with swallowing postoperatively; the
incidence among the three groups did not differ (71.4,
72.2, and 64.9 % in groups A, B and C, respectively;
p = 0.504; chi-square test) (Table 2). Procedure related
complications were rare; only one patient had transient
Table 1 Demographic data
Group A—control with
normal saline (n = 56)
Group B—0.5%
bupivacaine (n = 52)
Group C—0.5%
levobupivacaine (n = 54)
p Value
Age, years (range) 47.2 ± 13 (18–73) 44.4 ± 15.9 (15–77) 46.1 ± 14.1 (17–78) 0.731
Men/women 5/51 9/43 8/46 0.424
Bilateral thyroidectomy 24 (42.9%) 21 (40.4%) 21 (38.9%) 0.912
Unilateral thyroidectomy 32 (57.1%) 31 (59.6%) 33 (61.1%)
Thyroid cancer 9 (16.1%) 10 (19.2%) 12 (22.2%) 0.951
Nodular goiter 44 (78.6%) 39 (75.0%) 39 (72.2%)
Hyperthyroidism 3 (5.4%) 3 (5.8%) 3 (5.6%)
Number of patients needing additional
intraoperative fentanyl
24 (42.9%) 23 (44.2%) 23 (42.6%) 0.984
Mean dose of additional intraoperative
fentanyl (lg)
66.6 67.3 65.2 0.959
Table 2 Intraoperative and postoperative data
Group A (n = 56) Group B (n = 52) Group C (n = 54) p Value
Average end-tidal desﬂurane concentration (%) 5.8 (± 0.58) 3.9 (± 0.56) 3.8 (± 0.53) \0.001
Mean operative time (min) 152.9 (56.4–345) 156.4 (55–395) 164.1 (49–337) 0.492
Number of patients requiring analgesics within the ﬁrst 24 h 33 (58.9%) 8 (15.4%) 7 (13.0%) \0.001
Time to ﬁrst postoperative analgesic requirement (min) 82.1 (15–259) 360.8 (15–870) 410.1 (15–1,050) 0.0004
Number of patients with PONV (overall/severe) 21/8 19/5 15/6 –
Number of patients with swallowing pain 40 (71.4%) 40 (76.9%) 37 (68.5%) 0.504
Mean hospital stay (days) 2.9 (1–5) 2.5 (1–6) 2.4 (1–5) 0.011
PONV postoperative nausea and vomiting
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123diaphragmatic paresis and brachial plexus block (0.6%).
The patient only had transient unilateral phrenic nerve
and brachial plexus blocks with mild dyspnea and
weakness of the involved arm, which resolved spontane-
ously 6 h postoperatively. No patients reported awareness
during the operation.
Discussion
This prospectively randomized study showed that a bilat-
eral superﬁcial cervical block combined with general
anesthesia reduced postoperative pain and incidence and
duration of severe PONV in patients who underwent
thyroid and parathyroid operations.
Andrieu et al. [9] performed BSCPB with/without
clonidine and found reduced intraoperative and postoper-
ative analgesic requirement. However, other studies
showed that local and regional anesthetic techniques did
not decrease analgesic requirement after thyroid surgery
[10, 11]. These results were based only on postoperative
pain VAS and analgesic requirement. Procedure failure
and ineffective regional anesthesia may sometimes be a
problem. Unfortunately, there is no good method to con-
ﬁrm procedure success. Andrieu et al. used systolic blood
pressure recorded at induction, incision, end of resection,
and extubation to evaluate the process efﬁcacy [9]. Among
the three groups, we kept the same depth of anesthesia,
maintaining a target range of arterial-line autoregressive
index (AAI) between 15 and 25. The AAI is calculated
from the middle latency auditory evoked potentials (AEPs)
and the electroencephalogram (EEG), and it is helpful in
detecting intraoperative awareness with recall and
decreasing anesthetic requirements [12, 13]. Struys et al.
concluded that AAI monitoring is an accurate indicator of
the level of sedation and loss of consciousness [14]. Lu
et al. also demonstrated that, at an AAI of 20 ± 5, des-
ﬂurane can maintain an adequate anesthetic effect [12].
Therefore, if concentration of end-tidal desﬂurane is
reduced 1 h after BSCPB, it may help to conﬁrm proce-
dure success. In groups B and C in the present study,
lower average concentration of end-tidal desﬂurane both
proved the efﬁcacy of regional anesthesia and lowered the
incidence of PONV.
Different techniques and local anesthetic agents used for
BSCPB in previous studies could be another reason for the
controversy surrounding the use of this form of anesthesia.
There are two-point and three-point injection techniques
for BSCPB. The standard two-point injection technique is
to insert the needle at the junction of the upper and middle
thirds of the posterior border of the sternocleidomastoid
muscle at 1–2 cm depth (in a subcutaneous plane), then
inject 2–3 ml prepared anesthetic cephalad toward the
mastoid, and then inject the other 2–3 ml caudad toward
the clavicle [15]. The three-point injection technique added
the horizontal injection. Our technique of BSCPB is a
modiﬁed two-point injection. We skipped the injection
cephalad toward the mastoid; instead, we emphasized the
lower neck compartment. Dieudonne et al. used a three-
point injection with 10 ml of bupivacaine 0.25% and
1:200,000 epinephrine [4]. Andrieu et al. used a three-point
injection with 10 ml ropivacaine and clonidine [9].
2 Hr  4 Hr  8Hr 12Hr 16Hr 20Hr 24Hr
0
2
4
6
8
10
Post-OP
V
A
S
 
Group A  Group B  Group C  Fig. 1 Visual analog scale
(VAS) pain scores before
discharge from the
postanesthesia care unit (2 h
postoperatively), and at 6 h,
10 h, 14 h, 18 h, 22 h, and 26 h
after thyroidectomy or
parathyroidectomy. The box
represents the 25th and 75th
percentiles and the median is
represented by the solid line.
Error bars above and below the
box mark the 10th and 90th
percentiles. P-values at all time
period were less than 0.001
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123Eti et al. used a two-point injection with 0.25% bupiva-
caine 15 ml [10]. In addition to BSCPB, Suh, Inabnet, and
Pintaric [16–18] used combined (superﬁcial and deep)
cervical plexus block. Levobupivacaine is the S(-)-enan-
tiomer of the racemic local anesthetic bupivacaine. It is
superior to bupivacaine for its less toxic effect on the
central nervous and cardiovascular systems [19]. There are
few studies comparing the efﬁcacies of different local
anesthetics in cervical blocks. Levobupivacaine seems to
be more potent than bupivacaine in in vitro studies [20].
However, there is no difference between the two anes-
thetics in in vivo studies [21]. In our study, we found that
levobupivacaine has a slightly longer duration of action.
Local anesthetic wound inﬁltration (LWI) is an excellent
way to reduce postoperative pain in hernia operations [22].
For deeper procedures like thyroidectomy, the results are
conﬂicting. Some investigators found BSCBP to be supe-
rior to LWI [1]; however Dieudonne et al. found no dif-
ference in reduction of postoperative analgesic requirement
between the two techniques [4]. The reason for the con-
troversy might be that there is no standard way to perform
LWI, which affects a relatively smaller, more superﬁcial
acting area and is of shorter duration.
Nausea and vomiting after neck operations can be
caused by intubations, inhalation anesthetics, perioperative
analgesics, and surgical manipulation. Sonner et al.
reported that 54% of their patients had nausea and vomiting
after thyroidectomy, with the incidence more common in
women and in those who had inhalation anesthesia. They
scored postoperative nausea and vomiting (PONV) after
thyroidectomy as grades 1–4 and deﬁned severe PONV as
grades 3 and 4 [2]. Our incidence of PONV in the three
groups was 32.9%. This lower rate may be related to our
routine use of 5 mg dexamethasone intravenously during
thyroid operations [23]. Fewer patients in our groups B and
C developed severe PONV. Unfortunately, our study did
not have a large enough number of patients to detect dif-
ferences in PONV among the three groups.
Post-thyroidectomy swallowing pain has received less
attention in the literature. Suh et al. reported that bilateral
superﬁcial cervical plexus block with or without deep cer-
vical plexus block reduced incision pain at rest and on
swallowing at 0, 2, and 4 hpostoperatively. They concluded
that BSCPB is an effective technique with fewer side effects
and greater patient satisfaction [16]. Again, in our study,
because of the insufﬁcient number of patients, there was no
statistically valid basis from which to conclude if there was
a difference in postoperative swallowing pain among the
three groups. Superﬁcial cervical block may not be able to
cover deeper compartments to alleviate swallowing pain.
We do not use deep cervical blockbecause of the higher rate
of complications, such as intravenous injection, hematoma,
nerve injury, and unintended blockade of vagus nerve,
brachial plexus [17], or phrenic nerve [24]. We had one
patient (0.6%) who had a phrenic nerve and brachial plexus
block that resolved after 6 h. She was thin and the injection
was likely deeper than intended.
Cervical plexus block without general anesthesia is an
option. Pintaric et al. used either superﬁcial or combined
cervical plexus block (CCPB) without general anesthesia
effectively in minimally invasive parathyroidectomy [18].
Inabnet et al. and Arora et al. [17, 25] also found regional
and local anesthesia without general anesthesia to be safe
for same-day discharge after thyroidectomy. We have
occasionally used superﬁcial cervical plexus block without
general anesthesia in high-risk patients. Factors that inﬂu-
ence this decision may include goiter size, extent of
operation, airway protection, ﬁre risk, neck pressure,
coughing during surgical manipulation, and patient anxi-
ety. The percentage of conversion to general anesthesia
was 1.8% because of ineffective anesthesia and changes in
operative extent [17]. Contraindications for local/regional
anesthesia without general anesthesia for thyroid surgery
may include communication barrier (dementia, language
barrier, mental retardation), planned sternotomy (retro-
sternal extension), additional procedures, known or sus-
pected locally invasive cancer, allergy to local anesthetics,
patient preference for general anesthesia, and cervical
lymphadenectomy [25]. Either BSCPB or bilateral CCPB
combined with general anesthesia may be safer and more
widely applicable in low anesthetic risk patients.
In conclusion, bilateral superﬁcial cervical plexus block
is effective in reducing the amount of general anesthetic
required during thyroidectomy. It also signiﬁcantly lowers
the severity of postoperative pain during the ﬁrst 24 h and
shortens the hospital stay.
Acknowledgments The study was supported by grants from Tri-
service General Hospital of Taiwan (TSGH-C96-72). The paper was
presented at the International Surgical Week 2009, Adelaide, Aus-
tralia, 6–10, September 2009. The author, Shih, was the winner of
Selwyn Taylor Award for the best poster of endocrine surgery.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Lacoste L, Thomas D, Kraimps JL et al (1997) Postthyroidecto-
my analgesia: morphine, buprenorphine or bupivacaine? J Clin
Anesth 9:189–193
2. Sonner JM, Hynson JM, Clark O et al (1997) Nausea and vom-
iting following thyroid and parathyroid surgery. J Clin Anesth
9:398–402
3. Gozal Y, Shapira SC, Gozal D et al (1994) Bupivacaine wound
inﬁltration in thyroid surgery reduces postoperative pain and
opioid demand. Acta Anaesthesiol Scand 38:813–815
2342 World J Surg (2010) 34:2338–2343
1234. Dieudonne N, Gomola A, Bonnichon P et al (2001) Prevention of
postoperative pain after thyroid surgery: a double-blind ran-
domized study of bilateral superﬁcial cervical plexus blocks.
Anesth Analg 92:1538–1542
5. Aunac S, Carlier M, Singelyn F et al (2002) The analgesic efﬁ-
cacy of bilateral combined superﬁcial and deep cervical plexus
block administered before thyroid surgery under general anes-
thesia. Anesth Analg 95:746–750
6. Kuo CP, Chen KM, Wu CT et al (2006) Utility of the auditory
evoked potentials index as an indicator for endotracheal intuba-
tion. Acta Anaesthesiol Taiwan 44:205–210
7. Fujii Y (2008) The beneﬁts and risks of different therapies in
preventing postoperative nausea and vomiting in patients under-
going thyroid surgery. Curr Drug Saf 3:27–34
8. Fujii Y (2006) Prophylaxis of postoperative nausea and vomiting
in patients scheduled for breast surgery. Clin Drug Investig
26:427–437
9. Andrieu G, Amrouni H, Robin E et al (2007) Analgesic efﬁcacy
of bilateral superﬁcial cervical plexus block administered before
thyroid surgery under general anaesthesia. Br J Anaesth 99:
561–566
10. Eti Z, Irmak P, Gulluoglu BM et al (2006) Does bilateral
superﬁcial cervical plexus block decrease analgesic requirement
after thyroid surgery? Anesth Analg 102:1174–1176
11. Herbland A, Cantini O, Reynier P et al (2006) The bilateral
superﬁcial cervical plexus block with 0.75% ropivacaine
administrated before or after surgery dose not prevent postoper-
ative pain after total thyroidectomy. Reg Anesth Pain Med
31:31–39
12. Lu CH, Borel CO, Wu CT et al (2005) Combined general-epi-
dural anesthesia decreases the desﬂurane requirement for equiv-
alent A-line ARX index in colorectal surgery. Acta Anaesthesiol
Scand 49:1063–1067
13. Horng HC, Kuo CP, Ho CC et al (2007) Cost analysis of three
anesthetic regimens under auditory evoked potentials monitoring
in gynecologic laparoscopic surgery. Acta Anaesthesiol Taiwan
45:205–210
14. Struys MS, Eric WJ, Warren S et al (2002) Performance of the
ARX-derived auditory evoked potential index as an indicator of
anesthetic depth. A comparison with Bispectral Index and
hemodynamic measures during propofol administration. Anes-
thesiology 96:803–816
15. Morgan GE Jr, Mikhail MS, Murray MJ (2006) Peripheral nerve
blocks. Section III. Regional anesthesia & pain management,
chapter 17. Clinical anesthesiology. McGraw-Hill, New York,
pp 353–354
16. Suh YJ, Kim YS, In JH et al (2009) Comparison of analgesic
efﬁcacy between bilateral superﬁcial and combined (superﬁcial
and deep) cervical plexus block administered before thyroid
surgery. Eur J Anaesthesiol 26:1043–1047
17. Inabnet WB, Shifrin A, Ahmed L et al (2008) Safety of same day
discharge in patients undergoing sutureless thyroidectomy: a
comparison of local and general anesthesia. Thyroid 18:57–61
18. Pintaric TS, Hocevar M, Jereb S et al (2007) A prospective,
randomized comparison between combined (deep and superﬁcial)
and superﬁcial cervical plexus block with levobupivacaine for
minimally invasive parathyroidectomy. Anesth Analg 105:
1160–1163
19. Foster RH, Markham A (2000) Levobupivacaine: a review of its
pharmacology and use as a local anesthetic. Drugs 59:551–579
20. Kanai Y, Katsuki H, Takasaki M (2000) Comparisons of the
anesthetic potency and intracellular concentrations of S(-) and
R(?) bupivacaine and ropivacaine in crayﬁsh giant axon in vitro.
Anesth Analg 90(2):415–420
21. Baskan S, Taspinar V, Ozdogan L et al (2010) Comparison of
0.25% levobupivacaine and 0.25% bupivacaine for posterior
approach interscalene brachial plexus block. J Anesth 24:38–42
22. Dahl JB, Moiniche S, Kehlet H (1994) Wound inﬁltration with
local anaesthetics for postoperative pain relief. Acta Anaesthesiol
Scand 38:7–14
23. Fujii Y, Nakayama M (2007) Efﬁcacy of dexamethasone for
reducing postoperative nausea and vomiting and analgesic
requirements after thyroidectomy. Otolaryngol Head Neck Surg
136:274–277
24. Weiss A, Isselhorst C, Gahlen J et al (2005) Acute respiratory
failure after deep cervical plexus block for carotid endarterec-
tomy as a result of bilateral recurrent laryngeal nerve paralysis.
Acta Anaesthesiol Scand 49:715–719
25. Arora N, Dhar P, Fahey TJ III (2006) Seminars: local and
regional anesthesia for thyroid surgery. J Surg Oncol 94:708–713
World J Surg (2010) 34:2338–2343 2343
123